Duffield Jeremy has filed 3 insider transactions across 1 company since March 2023.
Most recent transaction: a grant/award of 275000 shares of Prime Medicine, Inc. ($PRME) on February 27, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 27, 2025 | Prime Medicine, Inc. | $PRME | Duffield Jeremy | Chief Scientific Officer | A | Stock Option (right to buy) | 275000 | $0.00 | 275,000.0000 | 131,160,842 | 9999.99% | 0.21% |
| Feb. 21, 2024 | Prime Medicine, Inc. | $PRME | Duffield Jeremy | Chief Scientific Officer | A | Stock Option (right to buy) | 180995 | $0.00 | 180,995.0000 | 0 | 9999.99% | 0.00% |
| March 31, 2023 | Prime Medicine, Inc. | $PRME | Duffield Jeremy | Chief Scientific Officer | A | Stock Option (right to buy) | 180995 | $0.00 | 180,995.0000 | 0 | 9999.99% | 0.00% |